BE806158A - Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine - Google Patents

Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine

Info

Publication number
BE806158A
BE806158A BE136763A BE136763A BE806158A BE 806158 A BE806158 A BE 806158A BE 136763 A BE136763 A BE 136763A BE 136763 A BE136763 A BE 136763A BE 806158 A BE806158 A BE 806158A
Authority
BE
Belgium
Prior art keywords
ergokryptine
ergocornine
bromo
alpha
medicinal product
Prior art date
Application number
BE136763A
Other languages
English (en)
French (fr)
Inventor
K Fuxe
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE806158A publication Critical patent/BE806158A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE136763A 1972-10-18 1973-10-16 Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine BE806158A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1524172 1972-10-18
ZA00738106A ZA738106B (en) 1972-10-18 1973-10-18 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
BE806158A true BE806158A (fr) 1974-04-16

Family

ID=25715971

Family Applications (1)

Application Number Title Priority Date Filing Date
BE136763A BE806158A (fr) 1972-10-18 1973-10-16 Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine

Country Status (5)

Country Link
AU (1) AU6145873A (es)
BE (1) BE806158A (es)
DE (1) DE2351609A1 (es)
NL (1) NL7314066A (es)
ZA (2) ZA738106B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
IT1200603B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutiche ad attivita dopaminergica
GB8514089D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Pharmaceutical tablet
IT1235053B (it) * 1989-04-07 1992-06-17 Poli Ind Chimica Spa Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.

Also Published As

Publication number Publication date
ZA738106B (en) 1975-05-28
NL7314066A (es) 1974-04-22
AU6145873A (en) 1975-04-17
ZA738103B (en) 1975-05-28
DE2351609A1 (de) 1974-04-25

Similar Documents

Publication Publication Date Title
BE839632A (fr) Medicament a base de sulfadiazine zincique
BE792131A (fr) Dispositifs pour l'injection de medicaments
BE790813A (fr) Seringue d'injection
BE801453A (fr) Dispositif pour administrer des medicaments
FR2293198A1 (fr) Medicament contenant un derive de s-dioxyde de thioxanthone
BE808103A (fr) Seringue d'injection
IT1045864B (it) Accouplement d'ambre
FR2289184A1 (fr) Medicament contenant un derive de carboxy-thioxanthone
BE808441A (fr) Medicaments a base de derives de bisphenol-alcanes
FR2313075A1 (fr) Medicament a base de l-pyroglutamyl-l-histidyl-l-prolinamide ou ses sels
FR2307541A1 (fr) Medicament a base d'un polypeptide
BE767707A (fr) Medicament a base d'un derive de l'aminoacetonitrile
BE806158A (fr) Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine
BE802995A (fr) Medicament a base d'un derive de l'oxindole
BE787523A (fr) Medicament a base de pyridone-2
BE877157A (fr) Medicament a base de derives de la thienopyridone ou de la furopyridone
BE811547A (fr) Medicament a base d'un derive de la 7h-benzocycloheptene-7-one
BE770844A (fr) Medicament a base d'un derive de diphenyl-alcane
BE801014A (fr) Medicament a base d'(hydroxy-2 indanyl-2)1 propylamine
BE823487A (fr) Medicament a base de vincamine
BE819833A (fr) Medicament a base de beta-1-glycoproteine
BE771112A (fr) Medicament a base d'un derive de l'aminoguanidine
BE803796R (fr) Medicament a base d'un derive de diphenylalcane
BE823485A (fr) Nouveau medicament a base de vincamine
BE796592R (fr) Medicament a base de p-chlorophenoxyisobutyrate de pyridoxine